Home Healthcare Pharmaceuticals Specialty Injectable Generics Market

Specialty Injectable Generics Market Size, Share & Trends Analysis Report By Type (Small Molecules, Biologic), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Others), By Therapeutic Application (Oncology, Autoimmune Disorders, Infectious Diseases, Cardiovascular Diseases, Endocrine Disorders, Pain Management, Respiratory Disorders, Others), By Distribution Channel (Specialty Pharmacy, Drug Stores & Retail Pharmacy, Hospital Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 07, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Specialty Injectable Generics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Small Molecules
    2. Biologic
  2. Specialty Injectable Generics Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Intravenous
    2. Intramuscular
    3. Subcutaneous
    4. Others
  3. Specialty Injectable Generics Market, By Therapeutic Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Autoimmune Disorders
    3. Infectious Diseases
    4. Cardiovascular Diseases
    5. Endocrine Disorders
    6. Pain Management
    7. Respiratory Disorders
    8. Others
  4. Specialty Injectable Generics Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Specialty Pharmacy
    2. Drug Stores & Retail Pharmacy
    3. Hospital Pharmacy
  5. Regional Specialty Injectable Generics Market
    1. North America
      1. North America Specialty Injectable Generics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologic
      2. North America Specialty Injectable Generics Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Subcutaneous
        4. Others
      3. North America Specialty Injectable Generics Market By Therapeutic Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Endocrine Disorders
        6. Pain Management
        7. Respiratory Disorders
        8. Others
      4. North America Specialty Injectable Generics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Specialty Pharmacy
        2. Drug Stores & Retail Pharmacy
        3. Hospital Pharmacy
      5. U.S.
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      6. Canada
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
    2. Europe
      1. Europe Specialty Injectable Generics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologic
      2. Europe Specialty Injectable Generics Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Subcutaneous
        4. Others
      3. Europe Specialty Injectable Generics Market By Therapeutic Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Endocrine Disorders
        6. Pain Management
        7. Respiratory Disorders
        8. Others
      4. Europe Specialty Injectable Generics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Specialty Pharmacy
        2. Drug Stores & Retail Pharmacy
        3. Hospital Pharmacy
      5. U.K.
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      6. Germany
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      7. France
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      8. Spain
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      9. Italy
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      10. Russia
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      11. Nordic
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      12. Benelux
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      13. Rest of Europe
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
    3. APAC
      1. APAC Specialty Injectable Generics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologic
      2. APAC Specialty Injectable Generics Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Subcutaneous
        4. Others
      3. APAC Specialty Injectable Generics Market By Therapeutic Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Endocrine Disorders
        6. Pain Management
        7. Respiratory Disorders
        8. Others
      4. APAC Specialty Injectable Generics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Specialty Pharmacy
        2. Drug Stores & Retail Pharmacy
        3. Hospital Pharmacy
      5. China
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      6. Korea
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      7. Japan
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      8. India
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      9. Australia
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      10. Taiwan
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      11. South East Asia
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      12. Rest of Asia-Pacific
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
    4. Middle East and Africa
      1. Middle East and Africa Specialty Injectable Generics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologic
      2. Middle East and Africa Specialty Injectable Generics Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Subcutaneous
        4. Others
      3. Middle East and Africa Specialty Injectable Generics Market By Therapeutic Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Endocrine Disorders
        6. Pain Management
        7. Respiratory Disorders
        8. Others
      4. Middle East and Africa Specialty Injectable Generics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Specialty Pharmacy
        2. Drug Stores & Retail Pharmacy
        3. Hospital Pharmacy
      5. UAE
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      6. Turkey
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      7. Saudi Arabia
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      8. South Africa
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      9. Egypt
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      10. Nigeria
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      11. Rest of MEA
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
    5. LATAM
      1. LATAM Specialty Injectable Generics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecules
        2. Biologic
      2. LATAM Specialty Injectable Generics Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Subcutaneous
        4. Others
      3. LATAM Specialty Injectable Generics Market By Therapeutic Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Disorders
        3. Infectious Diseases
        4. Cardiovascular Diseases
        5. Endocrine Disorders
        6. Pain Management
        7. Respiratory Disorders
        8. Others
      4. LATAM Specialty Injectable Generics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Specialty Pharmacy
        2. Drug Stores & Retail Pharmacy
        3. Hospital Pharmacy
      5. Brazil
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      6. Mexico
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      7. Argentina
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      8. Chile
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      9. Colombia
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
      10. Rest of LATAM
        1. Small Molecules
        2. Biologic
        3. Intravenous
        4. Intramuscular
        5. Subcutaneous
        6. Others
        7. Oncology
        8. Autoimmune Disorders
        9. Infectious Diseases
        10. Cardiovascular Diseases
        11. Endocrine Disorders
        12. Pain Management
        13. Respiratory Disorders
        14. Others
        15. Specialty Pharmacy
        16. Drug Stores & Retail Pharmacy
        17. Hospital Pharmacy
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.